Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT00352859
What this trial is testing

Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib

Who this might be right for
Carcinoma, Renal Cell
Bayer 2
Early research (Phase 1)Study completedNCT00094003
What this trial is testing

Study of NS-9 in Patients With Liver Metastases

Who this might be right for
Liver NeoplasmsNeoplasm MetastasisLocal Neoplasm Recurrences
NS Pharma, Inc. 20
Early research (Phase 1)Ended earlyNCT01943188
What this trial is testing

Stereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
Stanford University 2
Not applicableEnded earlyNCT01740154
What this trial is testing

Sunitinib Malate Related Fatigue in Patients With Metastatic Kidney Cancer

Who this might be right for
FatigueRecurrent Renal Cell CancerStage IV Renal Cell Cancer
Case Comprehensive Cancer Center 13
Early research (Phase 1)Not Yet RecruitingNCT06383507
What this trial is testing

A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+4 more
Zhejiang University 18
Testing effectiveness (Phase 2)Study completedNCT02136121
What this trial is testing

Prospective Investigation of Robotic Single-port System

Who this might be right for
Prostate and Kidney Cancer
Intuitive Surgical 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT06480565
What this trial is testing

A Phase 1/2 Trial of ADI-270 in ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Adicet Therapeutics 60
Early research (Phase 1)Ended earlyNCT05909995
What this trial is testing

Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors

Who this might be right for
MelanomaHepatocellular Carcinoma (HCC)Renal Cell Carcinoma (RCC)+3 more
Incyte Corporation 8
Not applicableWithdrawnNCT00858975
What this trial is testing

Study of Cryotherapy for Renal Tumors

Who this might be right for
Renal Tumors
National Taiwan University Hospital
Large-scale testing (Phase 3)Study completedNCT02829775
What this trial is testing

Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical Studies

Who this might be right for
Chronic Myelogenous LeukemiaMalignant MelanomaRenal Cell Carcinoma
Hoffmann-La Roche 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT07047001
What this trial is testing

Vorolanib Monotherapy or in Combination With Toripalimab as Adjuvant Therapy for Patients With Intermediate-high Risk of Recurrence in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma (RCC)Adjuvant
Dong Wen 60
Early research (Phase 1)Study completedNCT00656734
What this trial is testing

Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer.

Who this might be right for
Kidney Cancer
Bristol-Myers Squibb 27
Testing effectiveness (Phase 2)Study completedNCT00609934
What this trial is testing

Study of Sorafenib and Palliative Radiotherapy in Kidney Cancer That Spreads to the Bone

Who this might be right for
Renal Cell Carcinoma
University Health Network, Toronto 12
Not applicableStudy completedNCT00005799
What this trial is testing

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+42 more
Fred Hutchinson Cancer Center 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07218692
What this trial is testing

RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaAdvanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell Carcinoma+6 more
City of Hope Medical Center 35
Not applicableActive Not RecruitingNCT03291028
What this trial is testing

Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

Who this might be right for
Renal Cell CarcinomaUrothelial CarcinomaBladder Cancer+2 more
Fox Chase Cancer Center 15
Not applicableStudy completedNCT01608165
What this trial is testing

A Feasibility Study for a Multicentre Randomised Controlled Trial to Compare Surgery With Needle Ablation Techniques in People With Small Renal Masses (4cm)

Who this might be right for
Renal Cancer
Newcastle-upon-Tyne Hospitals NHS Trust 17
Early research (Phase 1)Study completedNCT02077933
What this trial is testing

Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors

Who this might be right for
NeoplasmsBreast NeoplasmsKidney Neoplasms+1 more
Novartis Pharmaceuticals 79
Testing effectiveness (Phase 2)Study completedNCT01688999
What this trial is testing

Cabozantinib for Advanced Urothelial Cancer

Who this might be right for
Urothelial CarcinomaUrethral NeoplasmsUrinary Bladder Neoplasms+1 more
National Cancer Institute (NCI) 69
Not applicableStudy completedNCT05444933
What this trial is testing

Collect Pre-existing Data on the Administration of Cabozantinib in Participants With Advanced Renal Cell Carcinoma (aRCC) Who Initiated Cabozantinib in 2nd Line in a Real-life Clinical Setting in France.

Who this might be right for
Advanced Renal Cell Carcinoma
Ipsen 252
Next Page